COVID-19 in China and the US: Differences in Hospital Admission Co-Variates and Outcomes
Article
[키워드] Admission
analyzed
Blood
blood lymphocyte
cardiac function
China
city
Clinical data
co-morbidity
cohorts
comparison
Concentration
coronavirus
COVID-19
death
difference
epidemiological
female
Fever
Hospital admission
hospital admission co-variates
Hospital stay
Hospitalization
hospitalizations
Hospitalized
ICU
IMV
intensive care
Intervention
Invasive mechanical ventilation
investigated
kidney
Laboratory
less
liver
lymphocyte
median
New York
New York City
Organ failure
outcome
outcomes
pandemic
people with COVID-19
receive
receiving
Region
risk of death
subject
subjects
the SARS-CoV-2
USA
with COVID-19
Wuhan
[DOI] 10.3390/vaccines10020326 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/vaccines10020326 PMC 바로가기 [Article Type] Article